Motorola Solutions Cloud Technologies Earn Highest FedRAMP Authorization Level

CHICAGO--(BUSINESS WIRE)--Feb 18, 2025--

Motorola Solutions (NYSE: MSI) today announced it has received the highest-level security authorization from the Federal Risk and Authorization Management Program (FedRAMP ® ) for its federal cloud. This FedRAMP High Authorization allows federal agencies to more quickly and seamlessly procure and deploy select Motorola Solutions cloud software, APX-series radios and APX radio applications which have already undergone the government’s rigorous testing process.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250218279396/en/

“Federal missions, operations and logistics are varied and complex, requiring resilient, scalable and highly secure communication solutions,” said Joe Balchune, vice president, Federal Markets, Motorola Solutions. “Federal agencies can now procure our purpose-built cloud solutions with confidence knowing that the way our technology handles sensitive, unclassified data has been assigned FedRAMP’s highest security authorization. State and local agencies also have the assurance that our technologies have been thoroughly tested to meet FedRAMP High federal security standards.”

The authorization includes Motorola Solutions’ APX-series radios and select APX radio applications, as well as the integration of these products with CommandCentral Aware cloud software. These technologies help to enhance connectivity, coordination and safety for government personnel.

FedRAMP is a federal government security and risk assessment standard that facilitates the evaluation and adoption of cloud-based solutions for federal agencies while validating the rigor of a company’s security controls and processes for entities like state and local governments. View Motorola Solutions’ FedRAMP marketplace page or website for a full list of authorized radios, applications and software.

About Motorola Solutions

Safety and security are at the heart of everything we do at Motorola Solutions. We build and connect technologies to help protect people, property and places. Our technologies support public safety agencies and enterprises alike, enabling the collaboration that’s critical for safer communities, safer schools, safer hospitals and safer businesses. Learn more about our commitment to innovating for a safer future for us all at www.motorolasolutions.com.

FedRAMP High Authorization allows federal agencies to more quickly and seamlessly procure and deploy select Motorola Solutions cloud software, APX-series radios and APX radio applications which have already undergone the government’s rigorous testing process. Photo credit: Motorola Solutions

WASHINGTON (AP) — Scientists stumbled onto a hint that measuring a toxic protein tied to Alzheimer’s disease just might one day be useful in diagnosing a different brain disease in football players and others who have suffered repeated blows to the head.

Doctors evaluate symptoms such as mood swings and memory loss to try to tell if patients may have CTE, or chronic traumatic encephalopathy, a disease linked to concussions and other brain trauma. But other diseases cause similar symptoms, and a CTE diagnosis can only be confirmed by examining the brain after death.

The new clue involves a protein called tau that normally supports neurons but becomes abnormal in Alzheimer’s, tangling inside those nerve cells. Researchers at Washington University in St. Louis were using autopsy samples to study a tau fragment called eMTBR-tau243 that may help track those tangles when they found something unusual: a patient with high levels of that biomarker even though records showed the person didn’t have Alzheimer’s but advanced CTE instead.

The researchers turned to a larger collection of autopsied brain and other samples, and eventually tested blood stored from 11 people who had been classified as having CTE.

Compared to healthy people, levels of eMTBR-tau243 were higher in those with advanced CTE, said study coauthor Chihiro Sato, a WashU assistant neurology professor. That biomarker couldn’t reliably identify early-stage CTE.

It is an interesting but very preliminary finding, requiring far larger studies to see if there is a real connection, cautioned Dr. Rudolph Castellani, a neuropathologist at Northwestern University who wasn’t involved with the research.

Abnormal tau is found in several brain diseases, many of which can overlap in older adults, adding to the difficulty in teasing apart its role in any one disease, including CTE. Sato, who studies such tauopathies, also stressed much more research is needed.

The findings were published late Friday by the medical journal JAMA and presented at a scientific meeting in Japan.

—-

The Associated Press’ health and science coverage receives financial support from the AP Fund for Journalism and private foundations. AP is solely responsible for all content. Find AP’s standards for working with philanthropies, a list of supporters and funded coverage areas at AP.org

FILE - A human brain affected by Alzheimer's disease is displayed at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y., on Oct. 7, 2003. (AP Photo/David Duprey, File)